Prevymis
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.prevymis.comRevenue
<$5 MillionIndustry
About Prevymis
Is Prevymis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Prevymis is spiking on competitors!
Check if Prevymis has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Prevymis launches new products
Congratulate Masked Content for being promoted to Masked Content at Prevymis
Click to see if Prevymis had a recent Job posting/layoffs
Prevymis, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Prevymis recently announced quarterly report
Funding: Get notified immidiatlly once Prevymis has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Prevymis
Compare insights from companies similar to Prevymis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Company Profile Activity
Activity Insights
Prevymis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Prevymis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Prevymis.
Prevymis Tech Stack
A closer look at the technologies used by Prevymis
Prevymis News & Media
AiCuris Announces Milestone Achievements Further Validating its Pipeline of Anti-viral Solutions for Immunocompromised Patients
WUPPERTAL, Germany--(BUSINESS WIRE)--AiCuris Anti-infective Cures AG, announced today multiple milestone achievements for letermovir (marketed by MSD as PREVYMIS®) and across its pipeline of anti-viral therapeutics serving the growing population of people whose immune systems are impacted due to disease or immunosuppressive therapies. These achievements recognize AiCuris’ rapid progress in developing a clinical pipeline of precise therapies to effectively treat infections in a population for wh
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Prevymis
Do not take PREVYMIS if you take pimozide or ergot alkaloids. If you are taking PREVYMIS with cyclosporine, do not take pitavastatin or simvastatin. Tell your doctor about all your medical conditions, including if you have kidney or liver problems; are pregnant or plan to become pregnant, since it is not known if PREVYMIS will harm your unborn baby... Read More